seen from China
seen from United States
seen from China
seen from Singapore
seen from Sweden
seen from Russia
seen from Australia
seen from United States
seen from Finland
seen from Netherlands
seen from Singapore
seen from Germany
seen from United States
seen from Hong Kong SAR China
seen from China
seen from United States
seen from Belarus
seen from France
seen from Netherlands
seen from United States
...
Às vezes me encontro ansiosa por alguma coisa. Isso faz tão mal! Ansiedade é um sentimento que corrói por dentro e deixa o ser humano sem esperança de ver o Sol brilhar novamente...
• Dica:
Toda vez que me encontro assim, oro ao Senhor para que tire isso de mim, leio a Palavra em voz alta e canto louvores de adoração ao Senhor. Fazer isso restaura meu espírito e traz renovo a minha mente e a meu coração. É impossível fazer isso e não se sentir melhor!
FDA approves first treatment Soliris (eculizumab) for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
FDA approves first treatment Soliris (eculizumab) for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. NMOSD is an autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord.
“Soliris provides the first FDA-approved…
View On WordPress
FDA approves new treatment Victoza (liraglutide) for pediatric patients with type 2 diabetes
FDA approves new treatment Victoza (liraglutide) for pediatric patients with type 2 diabetes
The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved to treat type 2 diabetes in pediatric patients since metformin was approved for pediatric use in 2000. Victoza has been approved to treat adult patients with type 2 diabetes since 2010.
“The…
View On WordPress
FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia
FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia
The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and older. The FDA initially approved Zerbaxa in 2014 to treat complicated intra-abdominal infections and for…
View On WordPress
FDA approves first treatment for pediatric patients with lupus
FDA approves first treatment for pediatric patients with lupus
The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous (IV) infusion for treatment of children with systemic lupus erythematosus (SLE) – often referred to as simply “lupus” – a serious chronic disease that causes inflammation and damage to various body tissues and organs. This is the first time that the FDA has approved a treatment for pediatric patients with SLE.…
View On WordPress
FDA approves new treatment for patients with acute myeloid leukemia
FDA approves new treatment for patients with acute myeloid leukemia
FDA approves new treatment Daurismo (glasdegib) for patients with acute myeloid leukemia The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic…
View On WordPress
FDA approves new drug Aemcolo (rifamycin), to treat travelers’ diarrhea
FDA approves new drug Aemcolo (rifamycin), to treat travelers’ diarrhea
FDA approves new drug to treat travelers’ diarrheaThe U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. “Travelers’ diarrhea affects millions of people each year and having…
View On WordPress
FDA approves first treatment Libtayo (cemiplimab-rwlc) for advanced form of the second most common skin cancer
FDA approves first treatment Libtayo (cemiplimab-rwlc) for advanced form of the second most common skin cancer
FDA approves first treatment for advanced form of the second most common skin cancer
New drug targets PD-1 pathway
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative…
View On WordPress
